Recent Change of -11.36% in the Corbus Pharmaceuticals Holdings Inc. (CRBP) market price might lead to pleasant surprises – Invest Chronicle

Recent Change of -11.36% in the Corbus Pharmaceuticals Holdings Inc. (CRBP) market price might lead to pleasant surprises

At the end of the latest market close, Corbus Pharmaceuticals Holdings Inc. (CRBP) was valued at $0.24. In that particular session, Stock kicked-off at the price of $0.2302 while reaching the peak value of $0.24 and lowest value recorded on the day was $0.208. The stock current value is $0.21.Recently in News on May 11, 2022, Corbus Presents Latest Preclinical Data for CRB-601 at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference. CRB-601 is a highly potent and selective anti-αvβ8 integrin monoclonal antibody designed to block the activation of TGFb in the local tumor microenvironment. You can read further details here

Corbus Pharmaceuticals Holdings Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.6700 on 01/03/22, with the lowest value was $0.2080 for the same time period, recorded on 05/12/22.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Corbus Pharmaceuticals Holdings Inc. (CRBP) full year performance was -84.89%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Corbus Pharmaceuticals Holdings Inc. shares are logging -90.83% during the 52-week period from high price, and -8.70% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.23 and $2.29.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2065458 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Corbus Pharmaceuticals Holdings Inc. (CRBP) recorded performance in the market was -65.89%, having the revenues showcasing -48.82% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 28.31M, as it employees total of 41 workers.

Specialists analysis on Corbus Pharmaceuticals Holdings Inc. (CRBP)

During the last month, 0 analysts gave the Corbus Pharmaceuticals Holdings Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 0.4368, with a change in the price was noted -0.48. In a similar fashion, Corbus Pharmaceuticals Holdings Inc. posted a movement of -69.65% for the period of last 100 days, recording 1,143,843 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CRBP is recording 0.28 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.23.

Trends and Technical analysis: Corbus Pharmaceuticals Holdings Inc. (CRBP)

Raw Stochastic average of Corbus Pharmaceuticals Holdings Inc. in the period of last 50 days is set at 0.48%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 0.96%. In the last 20 days, the company’s Stochastic %K was 2.72% and its Stochastic %D was recorded 2.84%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -65.89%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -79.00%, alongside a downfall of -84.89% for the period of the last 12 months. The shares increased approximately by -33.35% in the 7-day charts and went up by -48.50% in the period of the last 30 days. Common stock shares were lifted by -48.82% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts